Amino Acid, Peptide, or ProteinDisease or SyndromeENTITY HHS Terminates Funding for GeoVax’s Next-Generation COVID-19 Vaccine: Impacts and Developments 7 days ago talkbio0Tagged BARDA, CHARGE Syndrome, Clinical Trials, COVID19 (disease), development aspects, GeoVax, Immunocompromised Host, pandemic preparedness, Project NextGen, Termination - Inactive Reason Code, Vaccines Sources: